News > AstraZeneca plans new vaccine trial as efficacy questioned
AstraZeneca plans new vaccine trial as efficacy questioned
Dais Newsfeed | 27/11/2020 09:31 AM | Click to read full article
AstraZeneca said on Thursday it was likely to conduct an additional global trial to assess the efficacy of the Covid-19 vaccine it was developing along with the University of Oxford after experts questioned its current studies and cited a lack of transparency around the late-stage clinical trials.
“Now that we’ve found what looks like a better efficacy we have to validate this, so we need to do an additional study,” the pharma group’s chief executive officer Pascal Soriot said.